Skip to content
contact@indiamedicine.orgLogin / Register
IMSDA
  • Home
  • About Us
  • Drugs
  • News
  • Knowledge
  • Members
  • Contact Us
Search for:
Menu Close
  • Home
  • About Us
  • Drugs
  • News
  • Knowledge
  • Members
  • Contact Us

india-pharmacy

  1. Home>
  2. News>
  3. india-pharmacy>
  4. Page 6

Understanding Biosimilars in India: CDSCO Approval & Buyer’s Guide 2026

  • Post published:August 8, 2026
  • Post category:Knowledge

India is known as the "Pharmacy of the World" for its low-cost generic medicines, but a quieter revolution is underway in a different category: biosimilars. These are near-copies of complex…

Continue Reading Understanding Biosimilars in India: CDSCO Approval & Buyer’s Guide 2026

Understanding Generic Semaglutide: A 2026 Buyer’s Guide to Indian GLP-1 Options

  • Post published:August 6, 2026
  • Post category:Knowledge

Semaglutide — the active ingredient in Novo Nordisk’s Ozempic (for type 2 diabetes) and Wegovy (for weight management) — has become one of the most in-demand medicines in the world.…

Continue Reading Understanding Generic Semaglutide: A 2026 Buyer’s Guide to Indian GLP-1 Options

CDSCO to Launch Digital Drug Regulatory Platform in 18 Months

  • Post published:August 5, 2026
  • Post category:News

India's central drug regulator is betting on digital technology to speed up drug approvals and sharpen oversight. The Central Drugs Standard Control Organisation (CDSCO) has announced plans to launch the…

Continue Reading CDSCO to Launch Digital Drug Regulatory Platform in 18 Months

Understanding Drug Patents and Generic Market-Entry Timing: A 2026 Buyer’s Guide

  • Post published:August 4, 2026
  • Post category:Knowledge

India is widely known as the "pharmacy of the world," but not every medicine can be bought as a cheap generic on day one. If a drug is still under…

Continue Reading Understanding Drug Patents and Generic Market-Entry Timing: A 2026 Buyer’s Guide
  • Go to the previous page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 19
  • Go to the next page

Recent Posts

  • CDSCO Mandates Pharma Companies to Maintain Adverse Event Reporting Systems
    September 1, 2026/
    0 Comments
  • India Pushes for Pharma Market Access in Argentina and Brazil
    August 31, 2026/
    0 Comments
  • India’s Pharma Ambitions Meet Regulatory Capacity: What Buyers Should Know
    August 30, 2026/
    0 Comments

Follow Us

IMSDA

Recent Posts

  • CDSCO Mandates Pharma Companies to Maintain Adverse Event Reporting Systems
  • India Pushes for Pharma Market Access in Argentina and Brazil
  • India’s Pharma Ambitions Meet Regulatory Capacity: What Buyers Should Know
  • CBN and PHARMEXCIL Sign MoU on Controlled Substances Exports
  • Understanding India’s Drug Safety Framework: A 2026 Buyer’s Guide

Contact Info

  • If you want to touch more medicine sales and distribution resources, you could contact us, or join us.
  • Address:2nd Floor, Bhavani CHS, Dadar West, Mumbai, 400028, Maharashtra.
  • Phone:+91 8048111688
  • Email:contact@indiamedicine.orgOpens in your application
  • Website:https://indiamedicine.org/
  • Home
  • About Us
  • Drugs
  • News
  • Knowledge
  • Members
  • Contact Us
© Copyright All Right Reserve